BU
Bio Usawa Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$500Ksold at filing
Total offeringNot stated
Investors in the raise7count reported to the SEC
FiledJan 27, 2026first sale Oct 30, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Richard ChinDirector
Vincent AncinettiDirector
John HautmanExecutive Officer
Menghis BairuExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.